Glycomics Market Size And Forecast To 2029

The global glycomics market size was valued at USD 924.5 million in 2022 and is projected to grow at a CAGR of 15.3% during the forecast period 2023 to 2029. One of the primary factors fueling the growth of the glycomics industry is the rise in the proteomics sector. The increase in research funding by different government agencies, as well as the increased need for sophisticated analytical methods for researching pathogen and human glycobiology in disease and health, are driving market expansion. The creation of innovative medications by pharmaceutical and biotechnology businesses, as well as the increased emphasis on glycomics and proteomics research investigations, all have an impact on the market. Furthermore, research and development, improved healthcare infrastructure, and an increase in pharmaceutical company spending all benefit the glycomics industry.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/glycomics-market

The Enzymes Segment is Dominating the Glycomics Market:
The Enzymes segment is expected to account for a larger revenue share and the market is expected to grow at double digit growth rate over the forecast years Glycomics employs a variety of research methods to quantify or characterise the glycome of a tissue, cell, or organism. Changes in the location or activity of enzymes involved in glycan biosynthesis result in a change in the final glycan structure. As a result, in addition to genetic markers, glycans may be studied to detect environmental changes. This research can help in illness diagnostics and medication development. This is one of the primary drivers of category expansion.

North America Leads Glycomics Market:
North America is expected to hold significant market share in the global Glycomics market and is projected to grow at a prominent growth rate over the forecast years Increasing investments in glycomics / glycobiology research, presence of all key players, along with the rising R&D investments in pharmaceutical companies for drug discovery. On the contrary, Asia Pacific is projected to witness modest growth during the forecast period owing to untapped market opportunities. Evolving pharmaceutical and biopharmaceutical industries have resulted in the immense growth of glycomics / glycobiology in the region.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global Glycomics market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance,, In June 2018, Shimadzu Corp. and PREMIER Biosoft, introduced its LCMS-9030 Quadruple Time of Flight (Q-TOF) mass spectrometry system. , In November 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System which is an integrated platform which is a user-friendly glycoanalysis.

The glycomics market is segmented based on product type, application, end user, and geography.
Based on the Product Type, the market is segmented into the following:
• Enzymes
• Instruments
• Kits
• Reagents

Based on the Application, the market is segmented into the following:
• Diagnostics
• Drug Discovery & Development
• Oncology, Immunology
• Other Applications

Based on the End-users, the market is segmented into the following:
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=854963

Key player's profiles in the Glycomics market report are Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US).

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet
particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.